Key facts: Eli Lilly to Cut Weight-Loss Drug Prices; Study Shows Spending Drop

Eli Lilly will cut US prices for its weight-loss drugs to $149 monthly for the lowest doses, coinciding with anticipated Medicare coverage expansion next year, reducing patient costs.1A Cornell study found households using Eli Lilly's Zepbound cut grocery spending by 5.3% in six months, with higher-income households reducing spending by 8.2%, especially on snacks.2